gyki 52466 has been researched along with Benign Neoplasms in 2 studies
GYKI 52466: an AMPA (non-NMDA) receptor antagonist; structure given in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "These findings suggest anticancer potential of glutamate antagonists." | 1.31 | Glutamate antagonists limit tumor growth. ( Ikonomidou, C; Rzeski, W; Turski, L, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rzeski, W | 1 |
| Turski, L | 1 |
| Ikonomidou, C | 1 |
| Cavalheiro, EA | 1 |
| Olney, JW | 1 |
2 other studies available for gyki 52466 and Benign Neoplasms
| Article | Year |
|---|---|
Glutamate antagonists limit tumor growth.
Topics: Anti-Anxiety Agents; Antineoplastic Agents; Benzodiazepines; Cell Division; Cell Movement; Cisplatin | 2001 |
Glutamate antagonists: deadly liaisons with cancer.
Topics: Animals; Anti-Anxiety Agents; Antineoplastic Agents; Benzodiazepines; Cell Movement; Dizocilpine Mal | 2001 |